The Nitrotyrosine Monoclonal Antibody Market is positioned for continued expansion as research organizations and pharmaceutical companies increase their focus on advanced antibody technologies. WiseGuyReports forecasts growth from approximately USD 500 million in 2024 to USD 1.5 billion by 2035, representing a CAGR of about 10.6%. Several factors are driving this development. The...